Crispr-Based Replacement Of The Endogenous T-Cell Repertoire With Novel, High-Avidity, Natural T Cell Receptors To Wt1 For The Treatment Of Acute Myeloid Leukemia

BONE MARROW TRANSPLANTATION(2021)

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要